FPHAX (Fidelity Sel Pharm)
Net Asset Value: 13.86 1-Day Return: -0.12 (-0.86%) YTD Return as of 5/23/12:Up 2.65%

Classification: GL Health/Biotechnology   Objective: GL Health/Biotech   Open to New Investors: Yes

Lipper Rating

Total Return Consistent Return Preservation Tax Efficiency Expense

The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.

NAV Chart | Growth of $10,000
Fund Chart
Find a Broker »

Total Returns (As of 5/23/2012)

More
 YTD1Yr3Yr5Yr10Yr
Fund 2.65 3.69 20.41 5.57 6.75
Classification 6.69 -1.51 13.57 2.10 5.00
Index (S&P 500) 5.80 2.30 16.50 -0.70 3.90
% Rank in Class (1-best,100=worst)85173323

Fund Stats

More
Investment Objective:GL Health/Biotech
Net Assets ($Mil)739.80
Inception Date:6/18/01
Manager Name, TenureAndrew Oh, 2006
Expense Ratio: 0.89%
Sales Charge:
Load Type:
  
No Load
0.00%
0.00%

Top 10 Holdings (As of 3/31/12)

More
Company NameSymbol% Net Assets
Merck & Co Inc Ord MRK 7.59
Sanofi Sa Dr SNY 7.38
Glaxosmithkline Plc Dr GSK 6.31
Pfizer Inc Ord PFE 4.61
Fidelity Revere Str Tr Taxable Cent Cash Fd NA 4.58
Valeant Pharmaceuticals International Inc Ord VRX 3.92
Novo Nordisk A/s Dr NVO 3.44
Teva Pharmaceutical Industries Ltd Dr TEVA 3.25
Allergan Inc Ord AGN 3.17
Abbott Laboratories Ord ABT 3.02
% of Total Holdings 47.27

View Overview for:

tools

Stock Screener

Portfolio Tracker

See More Tools
From the Magazine
Read More Read More Read More Read More

Also